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ABSTRACT
The present research was designed to determine if a single LSD
experience produces a detectable change in the electrical potential of
the brain, and if so, how long that change lasts, and to examine the
changes in the electrical potential of the brain associated with
Aemogenic and hypnogenic hallucinations.

Four studies were conducted

measuring the electrical potential between the front and back of the
head in monkeys and humans.

The frontal potential was shown to shift

negatively with the use of LSD-type psychedelics but not with marijuana
compounds.

LSD caused the potential in humans to shift into the range

commonly exhibited by hallucinating schizophrenics.

LSD-25 in a monkey

caused an extreme negative shift, while brom-LSD caused a small negative
shift, and THC caused no shift. There were no consistent shifts associated with hypnosis or hypnotic phenomena such as hypnogenic hallucinations or hypnoanalgesia.

The results indicated:

that LSD, unlike

marijuana compounds, caused a long-lasting but limited neurochemical
change in the user; that these neurochemical changes were not due to
hallucinations per se but may or may not have accompanied them; and
that chemogenic hallucinations and hypnotic hallucinations were not
based on a common physiological mechanism.
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INTRODUCTION

The present series of studies was undertaken to examine some
electrophysiological concomitants of hallucinations associated with the
use of psychedelic drugs (such as LSD and marijuana) , and with hypnotically-induced hallucinations.

Some of the main concerns were:

to

replicate some of the recent work of M. A. Cowen, who has published
thirty-two papers on a particular electrophysiological technique, of
which there are no replications by any other laboratory; to determine
whether or not LSD produces negative TCDC shifts in humans; and to examine the differences between chemogenic and hypnogenic hallucinations.
The primary research tool in the present investigation was the
transcephalic direct current potential (TCDC) measured across the
frontal and occipital areas. Although electroencephalography is the
best known method of measuring the electrical activity of the brain,
it is not the only method.

Libet and Gerard (1941) discovered a new

technique by measuring the electrical potential between the front and
the back of the cortex.

This potential is known as the TCDC. Record-

ings are usually taken over the frontal and occipital lobes (FO) with
the frontal lobe as the reference point.

However, in some studies,

recordings have also been taken over the temporal lobes (TT) simultaneously with the FO recordings.
Cowen (1967, 1970b) is the leading researcher of this TCDC
potential and in testing over 500 "normal" (i.e., non-psychiatric)
1

2

subjects during a three-year period, found that virtually all had a
TCDC(FO) potential between -18 mv and +20 mv, and that no subject
exceeded a peak negativity of -30 mv.

This -30 mv extreme was exceeded

by four of a group of ten college students who had taken psychotomectic
[sic] drugs (Friedman & Walker, 1970).

Unfortunately, neither the nature

of the drugs nor the peak TCDC(FO) was specified.

Although Cowen (1970a)

found that no "simple" schizophrenic surpassed a TCDC(FO) negativity of
over -30 mv, this level was exceeded by at least 40% of 96 hallucinating
schizophrenics.

The diagnosis of "hallucinatory", however, was obtained

from the patients' charts. The percentage was much higher in acute
hallucinating schizophrenics and much lower in chronic hallucinating
schizophrenics (Cowen, 1970a).

Cowen and Cassals (1968) found signifi-

cant differences (p< 0.01) in the TCDC(FO) potentials between 53 schizophrenics and 43 "normals".

Cowen (1968) found a high positive correla-

tion between frontal negativity and auditory, visual, or tactile hallucinations in schizophrenics.

In the case of tactile hallucinations, the

TCDC(FO) correlates of the hallucinators ranged from -30mv to -80 mv.'
There were no significant differences between the TCDC(FO) of 43
"normals" and 9 non-hallucinating psychiatric patients, but they differed
significantly (p< 0.001) from 34 hallucinating schizophrenics. Although
the subject who showed the most frontal negativity was almost always
hallucinating, not all subjects were hallucinating at the time of testing.

These findings suggested a detectable bio-electrical change accom-

panying hallucinations.
quency.

This raises the question of recency and fre-

Could a single psychedelic experience produce the TCDC(FO)

changes, and how long would these changes last?
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Electrically, the TCDC potentials are the slowly changing
aperiodic voltages recorded between specified diploic-emissary vein
distributions on the intact surface of the head.

They are highly corre-

lated with potentials of subjacent cortical sites (Ardini, 1961).

With

the frontal electrode as a reference, any increase of electrical activity
in the frontal lobe produces a negative shift (frontal negativity) in the
TCDC(FO).

Similarly, with the left temporal electrode as reference, any

increase in the electrical activity of the left temporal lobe produces a
negative shift in the TCDC(TT).
On the basis of many neurochemical studies, Cowen (1970b) has suggested that any substance that increases the amount of glutamic acid or
serotonin available to the brain should drive the TCDC(FO) negative.
All conceivable surface voltage sources have been examined as generators
of artifact.

The electro-oculographic component, even with both eyes

turned maximally upward, is less than 100 uv compared to TCDC(FO) potentials of +40 mv to -25 mv extremes in normal humans. There is no apparent direct-current component to either muscle activity per se or to EEG
"brain waves".

Scalp perspiration drives the TCDC(FO) positive and is

controlled in all studies by use of an air-conditioned room (Cowen,
1970b).

Scalp resistance measurements are epithelium-dependent and are

not correlated with TCDC potentials (Cowen, 1970b).

At least two sus-

pected schizophrenic substances, bufotenin and 3, 4 dimethoxyphenethylaime (DMPEA) affect serotonin levels (Gottlieb, 1968) and also produce
negative TCDC(FO) voltages.

In the rat, bufotenin in 0.2 ug doses and

DMPEA in 4.0 ug were effective in producing a negative TCDC(FO) (Cowen,
1970b), although Cowen did not report the range nor the magnitude of the
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shift.

Analgesics produced a near zero TCDC(FO) recording presumably

because of the depression of activity in the cortical sites.
Functionally, frontal negativity correlates with "orienting processes" whereby the brain reprograms itself to deal with novel and complex situations (Cowen, 1968).

Frontal positivity is associated with

defensive reflexes and withdrawal from the environmental stimuli (Cowen,
1967).

Left temporal TCDC electro-negativity correlates with intensive

recall and reprocessing of complex information.

Cowen (1970b) has

claimed differential characteristic TCDC abnormalities for various human
psychotic states including senility, childhood autism, and schizophrenia
although he did not specify the characteristics (except for the -30 mv
peak in hallucinating schizophrenics).
The Friedman and Walker study suggested that the use of "psychotomectic" drugs causes negative TCDC(FO) shifts not unlike that seen in
hallucinating schizophrenics. However, a major problem in assessing the
validity of research using "street-drugs" (i.e., drugs illegally produced
and marketed) is whether or not the street-drug was what it was represented to be; however, the action of many of the hallucinogens seem to
be neuro-chemically similar.

Much of the evidence accumulated over the

past years on the separate effects of LSD, mescaline and psilocybin has
in recent years been treated identically in distinguishing the subjective effects of the drugs.

Isbell (1959) has postulated some common

biochemical or physiological mechanism responsible for their effects
and, like Abramson (1960) and Abramson & Rolo (1967), has administered
both LSD and psilocybin in the same study of subjective effects of
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hallucinogens.

Malitz, Wilkens, & Esecover (1962) administered all

three in the same study and reported similar hallucinogenic behaviour
for all three.
The most direct support for assuming the equivalence of these
drugs comes from cross-tolerance studies.

Tolerance to one of the

hallucinogens is established by repeated administration (5-8 days)
which blocks or inhibits the action of the other hallucinogens (Abramson,
Skarlofsky, Baron & Fremont-Smith, 1958; Abramson, Rolo & Skarlofsky,
1960; Isbell, Wolback & Miner, 1961).

A new hallucinogen, 2, 5- dimethoxy-

4- methyl-amphetamine (DOM), has been found at dosages greater than 10 mg
to produce effects which resemble those produced by LSD, mescaline and
psilocybin (Hollister, et al., 1969; Snyder, Faillace, & Weingartner,
1968; and Snyder, Faillace, & Hollister, 1967).
Even if the equivalence of the hallucinogenic drugs is granted,
there remains the possibility that the "street" drugs contained no
pharmicologically active ingredients at all.
(1970), in an analysis of street drugs, found:

Cheek, Newell, and Joffe
(a) that of 15 samples

of alleged LSD, 14 were in fact LSD and one was Sernyl; (b) that of 13
samples of alleged mescaline, seven were LSD, four were "STP" (DOM), one
was aspirin, and one was chemically inactive; (c) of five alleged samples
of psilocybin, four were LSD and one was chemically inactive.

It is

certain that the subject could distinguish, barring placebo effect,
between the LSD-STP samples and the inert aspirin and gelatin powder.
Sernyl, although producing many of the same effects of LSD, also causes
tremor of the extremities.

The Le Dain Commission (19 70) reported that
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most street drugs in Canada are relatively pure, and contained LSD.
The relation between hallucinations of schizophrenic, hypnotic,
and chemogenic natures is uncertain.

Bliss and Clarke (1962) suggested

certain general relations, similarities, and differences among the
varieties of abnormal visual experiences.

The first main category is

the abnormal visual experiences that occur in "normal" people, e.g.,
sensory isolation phenomena, hypnotic states, and the results of some
functional neuroses and psychoses.

These visions are usually described

as realistic, rather than bizarre, and commonly as monochromactic or in
pale colour.

The second main category includes the visions of hypnogogic

states, dreams, and sleep deprivation.

All three conditions are asso-

ciated with semisomnolence and altered electroencephalographic activity.
These are posed as the workings of the mind in a "twilight zone" between
alertness and deep sleep, and presumably reflect the cortical dominance
of the visual apparatus at that time.

The visions caused by mescaline,

LSD, and other hallucinogens, as well as those resulting from withdrawal
states induced by drugs that depress the brain, are organized into a
third category.

In these instances, visual hallucinations are attribut-

able either directly to the disequilibrium or sudden withdrawal from the
agents.

These conditions seem to evoke bizarre, fantastic, and poly-

chromatic visions that differ radically from those in the first two
categories.
Solomon and Mendelson (1962) offered the following criteria in
Table 1 for differentiating altered states of consciousness: insight,
volition, and consciousness.
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INSERT TABLE 1 ABOUT HERE

Insight is the specific awareness of the reality or unreality of the
sense perception in question.

Volition distinguishes between mental

activity which is voluntary and willed, as opposed to that which is
spontaneous and uncontrolled.
sense of "out-thereness".)

(Where volition is absent, there is a

Consciousness is simply an awareness of

outer and inner reality.
The nature of the relation between psychogenic and chemogenic
hallucinations is uncertain.

Although they differ as to volition and

insight, many common features are shared:

they are both polyopic,

without size and shape constancy, with similar form-constants, and are
resistant to the influence of the beholder.

The Le Dain Commission

(1970, p. 317) distinguished between true hallucinations and pseudohallucinations :
A true hallucination includes the belief that the
abnormal perception is physically real, while a
pseudo-hallucination is recognized as being "unreal"
or a distortion of normal perception. Hallucinogenic
drugs usually produce pseudo-hallucinations rather
than true hallucinations, although in acute psychotic
reactions "reality contact" may be lost.
Perhaps the difference between true hallucinations and pseudo-hallucinations is the degree of attendant anxiety rather than differing biochemical mechanisms.
Some researchers have also claimed hallucinogenic effects for
large doses of marijuana and hashish (Kluver, 1928; Ames, 1958; Keeler,
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Reifler and Liptzin, 1968; and Keeler, 1968; Underleider, Fisher,
Goldsmith, Fuller and Forgy, 1968).

McGlothlin and West (1969) sum up

these claims:
In larger doses marijuana effects more closely resemble
those of the hallucinogens than any other group of drugs.
Most of the phenomena experienced with LSD, such as depersonalization, marked visual and temporal distortion,
and hallucinations have been observed with sufficiently
large amounts of marijuana and especially with hashish.
The effects are generally much milder and easier to
control than those of LSD.
Isbell, Gorodetzsk, Jasinski, Claussen, Spulak, and Korte (1967) have
recently demonstrated a similar dose effect with tetrahydrocannabinol
(THC), an active ingredient of marijuana, but found no cross tolerance
to the THC in subjects tolerant to LSD.

This would seem to indicate

that the two drugs act by different mechanisms and yet cause the same
psychological effects.
Researchers have long been examining another type of psychogenic
hallucination, that experienced by a subject while in a deep hypnotic
trance.

Halpern (1961) described an account of the induction of a

complex, unstructured hallucination in a young girl that resembled a
schizophrenic or chemogenic hallucination.

The unstructured halluci-

nation experienced by the girl is decidedly rare but the induction of
a positive hallucination is not. A positive hallucination is the perceiving of a stimuli that is not there.

Schneck (1953), Orne (1962),

Spanos and Barber (1968), Bowers and Gilmore (1969), and Gray, Bowers,
and Fenz (1970) have all reiterated that under deep trance, the subject
may experience positive or negative hallucinations.

The work of
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Erickson and Erickson (1938), Rosenthal and Mele (1952), and Barber
(1959) showed that subjects requested to hallucinate colours also
hallucinated the appropriate negative after-image.
Ludwig (1964), using highly structured positive hallucinations,
has been able to produce narcotic drug effects and withdrawal symptoms
in his subjects.

That subjects can hallucinate is no longer questioned,

but what relation hypnotically-induced hallucinations have with chemogenic and schizophrenic hallucinations is still conjecture.
Ravitz (1951), who has done extensive case work with d.c. potential correlates of hypnosis, found changes representing either a decrease
or an increase in potential in association with hypnotic phenomena.
However, he did not find any consistency in the direction of change but
this may be the result of the difference in electrode placement. He
used temporal-chest placements.

Friedman, Becker, and Bachman (1962),

in a fascinating study on hypnoanalgesia using the now standard frontaloccipital placements, found specific stable d.c. changes during hypnotic
induction.

More pertinent to the present paper, they found that hypno-

analgesia was accompanied by changes in the d.c. potential consistently
in the positive direction, demonstrating similarity to general and local
chemical anesthesia.

It seems reasonable to expect that if the TCDC is

similar for hypnotic and chemogenic analgesia, then the TCDC should also
be similar for hypnotic and chemogenic hallucinations.
One way of eliminating the varied legal and scientific problems
(involving set, setting, and preconceived ideas about LSD) in researching
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LSD is to use animals as subjects. Cowen (1970) has examined the
effects of LSD on the TCDC in rats and rabbits showing a positive correlation between peak negativity and reported strength of the hallucinogen
involved.

Thus far no work has been reported on the TCDC changes induced

by LSD in primates, either human or non-human.
Although, on the basis of the present study, it is easy to determine whether or not the TCDC(FO) changes during LSD intoxication in
monkeys are equivalent to those changes exhibited by humans, it is
impossible to determine whether or not the behavioural changes are also
equivalent.

Behavioural evidence that monkeys do experience halluci-

nations as a result of LSD is inadequate.

Cole and Glees (196 7) have

studied the effects of 100 ug/kg in monkeys and reported that the
animals' odd behaviour, (clutching at the air) could only be explained
on the basis of hallucinations.

However, Evarts (1956) used a dose of

1000 ug/kg of LSD in monkeys and found no such findings. Auerbach
(1971) has trained monkeys to make a different operant response to an
auditory signal when viewing slides of patterned stimuli as opposed to
plain or blank slides.

Subjects continued to make appropriate responses

to pictures following the administration of 10 ug/kg of LSD; their
failure to respond to blank slides as if they were patterned suggested
that LSD is not hallucinogenic in non-human primates.
The present research was designed to determine if a single LSD
experience produces a negative TCDC(FO) shift in primates, how long that
shift lasts, and to examine the TCDC(FO) correlates of chemogenic and
hypnogenic hallucinations.

STUDY I

Purpose

Study I was undertaken to determine whether or not a single
hallucinogenic experience had a long-lasting effect on the electrical
activity of the brain.

Cowen reported a high positive correlation

between excessive frontal negativity and schizophrenic hallucinations.
Additionally, Friedman and Walker reported excessive frontal negativity
in a group of college students who used psychotomectic drugs. This
suggested a connection between hallucinogenic substances and negative
TCDC(FO) recordings.

Method

Subjects:

Ten LSD-naive subjects, three female and seven male, between

the ages of 18 and 24 participated in this study.

The subjects were all

part of the university community who had volunteered for the experiment
advertised by a circular designed to recruit students already intending
to take LSD.

The circular is presented in Appendix A.

Those who had

experienced LSD prior to volunteering were tested, but their results
were excluded from the present study.

Apparatus:

All subjects were tested while seated in a soundproof, air-

conditioned, visually monotonous room.

Subjects were not allowed to

smoke tobacco for at least fifteen minutes prior to testing to eliminate
11
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any effects that the smoke might have had on the TCDC(FO) potential. A
direct current microvoltometer (Digitest, Model 19) was used for all
recording and was located in a separate room with the subject monitored
by means of a two-way mirror.

The j[ was grounded to the microvoltometer

by a metal stretch band on the left wrist.

A set of Beckman biopotential

skin electrodes was used with Beckman electrode paste for all recordings.
The baseline TCDC potential was measured by applying the electrodes in
the standard manner, on the midline surface of the head over the frontal
emissary vein distribution avoiding the frontal sinus area, and over the
occipital emissary vein distribution just above the superior external
occipital protuberance.

(See Figure 1 for placement of electrodes.)

INSERT FIGURE 1 ABOUT HERE

An elastic bandage was wrapped around the head to secure the electrodes
and to insure constant contact of the occipital electrode.

Electrode

impedance was measured to detect junction artifacts, and electrode
polorization was checked by touching (shorting) the electrodes together
and no significant artifacts were encountered.

The electrode output was

fed directly into the dc channel of the microvoltometer, set at 0-100
millivolts (mv).

Procedure:

E_ met the ^ when he arrived at the laboratory and asked that

the S^ refrain from smoking for the remainder of the session, and for
fifteen minutes prior to all subsequent sessions. During the first test
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session, the E_ administered a drug inventory (see Appendix B) . The jSs
in all of the present studies were screened on the basis of this questionnaire. All J3s who used either vitamins or antihistamines were
excluded because of the drugs' effects on the TCDC(FO), and all Ss who
reported never using any coffee, tea, aspirin, and tobacco were also
excluded on the basis of "abnormality".

The E_ then seated the S in a

comfortable lounge chair and connected the ground lead to the subject's
wrist.

The TCDC potential of each S^ was measured and recorded for a

ten-minute period.

Only the maximum frontal negativity reached by the

^ in the interval was reported.

After the Ss were tested, E_ asked them

to return in a week for a second testing.
the drug inventory was again administered.

After the second testing,
Again E_ requested the S^s to

make a subsequent appointment if they had ingested an LSD-type drug;
otherwise, an appointment would be made for them in a month to check
the stability of the measure.
Four S!s claimed to have ingested a street dose of an LSD-type
drug; all returned for testing.

They were matched according to sex and

day of testing with jSs who had reported no ingestion of LSD.
the ten Ss, two were not matched nor retested.

Thus, of

All drug Ss and their

matched controls were tested within five to seven days of the reported
drug experience.

Results

Because the TCDC technique is relatively new, and because the
validity of the parameters is somewhat uncertain, it is difficult to
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a s c e r t a i n whether or n o t a change i n t h e TCDC(FO) from +10 t o +15 i s
e q u i v a l e n t t o a change from - 5 to 0 .

The change i n e l e c t r i c a l

potential

i s o b v i o u s l y t h e same, b u t the changes i n n e u r o c h e m i s t r y t h a t produce
the energy changes may or may n o t be e q u i v a l e n t .

More i m p o r t a n t , i t

is

i m p o s s i b l e to t e l l i f -29 i s e s s e n t i a l l y d i f f e r e n t from -30 mv.
The peak TCDC(FO) i n mv f o r t h e drug and non-drug ^3s b e f o r e and
a f t e r a s i n g l e LSD-type e x p e r i e n c e i s p r e s e n t e d i n Table 2 and F i g u r e 2 .

INSERT TABLE 2 AND FIGURE 2
ABOUT HERE

The mean s h i f t f o r peak TCDC(FO) of t h e LSD group was - 3 6 . 5 mv (range
= - 2 8 t o -47) from p r e - t e s t t o f i r s t p o s t - t e s t .

This was c a l c u l a t e d by

summing t h e s h i f t s f o r each s u b j e c t and then a v e r a g i n g .

Similarly,

the

mean s h i f t of peak TCDC(FO) f o r the non-drug group was + 3 . 5 mv (range =
- 2 t o +7) from p r e - t e s t t o f i r s t p o s t - t e s t .

The mean s h i f t for each S^

was a l s o compared t o t h a t of h i s matched c o n t r o l .

On t h e b a s i s of

v i s u a l i n s p e c t i o n of t h e d a t a , i t was found t h a t t h e r e was no o v e r l a p
i n t h e peak n e g a t i v i t y of the c o n t r o l group over t i m e ; however, t h e peak
n e g a t i v e TCDC of t h e e x p e r i m e n t a l group d i f f e r e d s i g n i f i c a n t l y w i t h no
o v e r l a p from both t h e c o n t r o l group and t h e i r p r e - d r u g b a s e l i n e s .

The

time of day v a r i a b l e was randomly d i s t r i b u t e d throughout b o t h groups
and i n t h i s manner i t may have c o n t r i b u t e d - t o group v a r i a n c e , b u t did
not s i g n i f i c a n t l y b i a s any of t h e group peak TCDC p o t e n t i a l means.
number of days between t h e e x p e r i e n c e and t h e p o s t - e x p e r i e n c e

The

testing
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was not a significant variable.

One subject, Si, had a TCDC(FO) of -28

four months after initial ingestion.

Discussion

The data indicated that a single ingestion of reported LSD caused
a long-term change in the electrical activity of the brain, similar to
that reported in Cowen's studies of hallucinating schizophrenics. The
TCDC(FO) technique can presumably be used as a diagnostic tool to
detect the biochemical changes that occur with the use of an LSD-type
hallucinogen.
It is interesting to note that only one of the four experimental
subjects reported experiencing an hallucination (visual), and that the
£[ had by far the highest peak negativity (-41 mv) . It would have been
desirable to continue testing all the Ss periodically, until their baselines returned to normal but, unfortunately, all subjects were lost to
further study because they had either ended contact or resumed using
psychedelic drugs.

STUDY II

Purpose

Study I indicated that the LSD-induced changes in TCDC recordings
may be permanent or at least long lasting.

Cowen's report of frontal

negativity exceeding -30 mv in patients who had not reported an hallucination in years also suggested brain changes of substantial longevity.
Study II was designed to examine this seemingly long-lasting change.

Method

Subjects:

The subjects were six male previously LSD-active members of

the university community.

These subjects, between the ages of 18 and

30, had participated in a separate pilot study (Golemba, 19 70; see
Appendix C) while they were frequent users of LSD-type drugs. The E_
requested further tests and the Ss, who had stopped using "hard drugs"
for some four to five months previous, volunteered.

Apparatus:

The initial testing was performed using the same apparatus

used in Study I.

For final recording, the leads from the Beckman bio-

potential electrodes were attached to a standard physiograph ( E & M,
Model II).

Procedure:

The general procedure was the same as that used in Study I.

Initial and final testing were administered at the same time of day
approximately one week apart.

The E_ then administered a drug usage
16
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inventory, which is presented in Appendix B.

Those S^s who were using

vitamins or antihistamines were excluded from this study.

Results

Table 3 summarizes the peak TCDC(FO) in mv for LSD-active individuals during a period of high usage and after a period of abstinence.

INSERT TABLE 3 ABOUT HERE

Visual inspection of Figure 3 shows that there is a significant difference (no overlap) in the peak negativity TCDC(FO) of the Before and
After groups.

INSERT FIGURE 3 ABOUT HERE

The mean peak TCDC(FO) shift from usage to abstinence was +38.3 mv
(range = +14 to +56).

Every S^ shifted in a positive direction and was

well within the normal range after abstinence.

It is interesting to

note that three of the subjects (S2, S3, and S5) fell just within the
normal range even during their period of high usage.
The time of day of each recording was held constant and thus did
not significantly bias the means of the groups. Unfortunately, there is
not enough evidence to say whether number of "trips" was a significant
variable.

The three subjects who fell just within' the normal range had
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fewer trips than those who fell within the abnormal range.

Discussion

The changes in peak TCDC(FO) induced by an LSD experience were of
considerable but limited length.

It was interesting to note that the

two subjects with the highest negativity were the only ones who reported
hallucinations.

This may have been due to the dosage taken:

the

greater the amount of LSD, the greater the frontal negativity.

It is

also interesting to note that all Ss in this study returned to normal
range within an average of 13.2 weeks (range = 9 to 20), as opposed to
an abnormal TCDC(FO) for j[l of Study I, twenty weeks after a single
dose of LSD.

Either the duration of biochemical changes is highly

individualistic or the subject experienced further unreported LSD usage.

STUDY III

Purpose

Study III was designed to examine more fully some electrophysiological concomitants of two types of hallucinations:
hypnogenic.

chemogenic, and

Feinberg (1962) stated, "The more complex and organized

hallucinations (Stage IV of Kluver) induced in some persons by these
drugs [hallucinogens] do resemble schizophrenic hallucinations". And
Halpern (1961) has argued "that there is no essential qualitative difference between psychogenic [hypnogenic] and toxicogenic [chemogenic]
hallucinations".

Method

Subjects:

The £[s comprised two groups:

chemogenic and hypnogenic.

The

chemogenic subjects were eight volunteers recruited from the university
community by the same circular that was used in Study I.

The chemogenic

subjects were drug-active during testing; three were purportedly under
the influence of LSD, and the other five claimed to be under the influence of marijuana.

(The marijuana users were LSD-naive.)

Since all

drugs were street drugs and the Ss had consumed them before arriving at
the test laboratory, the dosage of active ingredients was impossible to
calculate.
For the hypnotic groups, a total of six highly susceptible Ss (one
of the six chosen was lost to analysis due to machine failure) and six
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unsusceptible JSs were selected for the experiment from a total of
twenty-five volunteers recruited from Introductory Psychology classes at
the University of Waterloo.

The E_ initially selected the j>s on the

basis of their high scores (7 to 10) on the Harvard Group Scale of
Hypnotic Susceptibility (HGSS, Shor and Orne, 1962).

The unsusceptible

Ss were selected on the basis of a score of 0 to 5 on the HGSS and were
assigned to a simulating condition.

As suggested by Hilgard and Tart

(1966) , simulators were used to minimize the possibility of their becoming inadvertently hypnotized during the course of the experiment.

Apparatus:

Recording of the chemogenic JSs was performed on a direct

Current microvoltometer (Digitest, Model 19), and all recording of the
hypnogenic Ss was performed on a two-channel dynograph (Beckman, type R
polygraph).

In both cases, Beckman biopotential skin electrodes were

used with Beckman electrode paste.
The stimulus for positive hallucinations was a five-by-seven-inch
white card with one completed triangle and one incomplete triangle drawn
on it with a black felt-tip pen (see Figure 4).

INSERT FIGURE 4 ABOUT HERE

The S^ was asked to hallucinate the closure of the incomplete triangle.

Procedure:
II.

The general procedure was the same as that of Studies I and

However, transtemporal recordings were made simultaneously with

frontal-occipital recordings (see Figure 1 for electrode placement).
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All recordings were made at 5 mv/cm sensitivity and the peak negativity
was recorded.
Chemogenic subjects were retested approximately one week after
initial testing.

During retest, the chemogenic subjects were drug-

active, that is, the marijuana subjects were under the influence of
marijuana and the LSD subjects were under the influence of LSD.
The research team was constituted as directed by The Hypnosis
Act, and the hypnosis was carried out by a supervised clinical doctoral
candidate at the University of Waterloo.
The E_ met the subjects in the hypnotic group at the laboratory
and ushered them into the testing room.

The E_ requested the ;S_ to sit

in a comfortable lounge chair and while the electrodes were applied,
the nature of the experiment was explained.

The E_ asked the j[s who

scored low on the HGSS, to co-operate with whatever the hypnotist (E2)
instructed them to do even though they would not be hypnotized, i.e.,
because of their low score on the HGSS, they could not be hypnotized.
The E_ told the Ss who scored high on the HGSS that they would be hypnotized and asked to perform certain tasks. To evaluate the effect of
suggestions on the TCDC, the E requested both groups to be completely
honest in the post-experimental interview.
After the E_ delivered the instructions, he went to an adjoining
room to obtain TCDC basal recordings.

Recordings were continuous up

until the beginning of the post-experimental interview.

Then the E2

met the subject and delivered hypnotic suggestions adapted closely from
those used on the Stanford Hypnotic Susceptibility Scale (SHSS,
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Weitzenhoffer and Hilgard, 1962).

When the S_ appeared to be deeply

hypnotized, the E2 gave instructions and suggestions for the unstructured hallucination.

The E2 told the S.:

In a moment I want you to imagine yourself walking
down a circular staircase. You cannot see the
bottom, but when you get to the bottom you will
see a scene, a very nice scene. You or I have no
idea what that scene will be, but it will be a
pleasant one . . . you are reaching the bottom;
you can see it now.
Here the E2 is suggesting a complex visual hallucination not unlike
Stage II of Kluver.

The S^was, after sixty seconds, asked to return up

the staircase, leaving the scene behind.

After having the S^ relax and

deepening the trance, the E2 delivered suggestions for the second phenomenon - dreaming:
In a moment you are going to have a dream; it will
be a real dream just like you experience at night.
Here the E2 is suggesting a dream state in order to compare TCDC
effects, if any, of dream images vs. hallucinatory images.
After again relaxing the S^ and deepening the trance, the E2 gave
instructions for the positive hallucination.

The E2 explained to the S^

that he was going to show him a five-by-seven-inch display card on which
there were two triangles printed.

Before actually opening his eyes, the

S± was given further instructions to deepen hypnosis and then to open his
eyes and describe what.he saw on the card.

The S^ was then asked to close

his eyes and deepen the trance.
Here the E2 is suggesting a positive hallucination and implicitly
eliciting a report of "I see two triangles".
One ^ (S_8) was subsequently given further suggestions to produce

anesthesia, and then the E2 awoke the S^ and told him that the E_ would
remove the electrodes momentarily.

Results

Hypnotic and Simulator Groups:

All the Ss who scored high on the HGSS

reported being hypnotized, while only one (S_4) of those scoring low reported being hypnotized.

Table 4 summarizes the subjective reports of

the j3s concerning their hypnotic experiences.

INSERT TABLE 4 ABOUT HERE

All subjects in the hypnotic group and one S_ in the simulator group reported that they "felt" hypnotized.

All but one of the hypnotic group

experienced the dream and the fantasy, and only one subject experienced
the positive hallucination.

Only one subject was given the hypnoanal-

gesic command and he reported it as being effective. Most of the subjects who reported experiencing the dream and the fantasy exhibited
rapid eye movements (REM's) with eyelids closed as would be expected
during night sleep.
Table 5 summarizes the peak TCDC(FO) changes of both the hypnotic
Ss and the simulators.

INSERT TABLE 5 ABOUT HERE
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There was no consistent difference in magnitude nor in direction of the
TCDC(FO) change associated with hypnosis.

Three of the hypnotic Ss

shifted frontally more positive while two became more negative.

In the

simulating group, two Ss became more frontally positive while four became frontally more negative (including the one simulator who reported
being hypnotized).

The expected negative shifts accompanying hypnogenic

hallucinations did not occur.

There were no differences in magnitude or

direction between hypnotized j>s who experienced the hallucination, hypnotized ^s who did not experience the hallucination, or simulating Ss.
Table 6 summarizes the TCDC changes associated with each suggestion.

INSERT TABLE 6 ABOUT HERE

The one subject (S_10) who received hypnoanalgesic suggestions reported
feeling numbed but the anticipated positive shift was absent.

This sub-

ject was an excellent hypnotic subject who experienced kinetic hallucinations, which are very rare.

There were no consistent changes asso-

ciated with any of the hypnotic phenomena exhibited by either the
hypnotized or the simulating subjects.

The trans temporal (TT) record-

ings produced no consistent data associated with any of the hypnotic
phenomena.

The expected left negative shifts associated with vivid

recall were not evident during the imagery-producing hallucinations.

Chemogenic Groups.

Table 7 summarizes the peak basal TCDC(FO) shifts
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for both pre-test and test sessions of marijuana users.

INSERT TABLE 7 ABOUT HERE

The Ss arrived approximately ten minutes after smoking between one half
and three of their own marijuana cigarettes.

Even a rough estimate of

the drug potency would be impossible to arrive at. All Ss reported
their marijuana to be of good quality, and all claimed to be "stoned".
There was no significant difference between pre-test and drug-active
test in the peak TCDC(FO) of the Ss. The mean peak TCDC(FO) at pre-test
was -5.6 mv (range = -15 to +5), while under the influence of marijuana
the mean was -1.4 mv (range = -10 to +10).

Even with the high dosage

(high in terms of normal use) of three cigarettes, there is no significant negative shift that would indicate an LSD-type change. Table 8
summarizes the peak basal TCDC(FO) shifts for both pre-test and test
sessions of LSD users.

INSERT TABLE 8 ABOUT HERE

The jSs arrived approximately fifteen minutes after the ingestion of one
tablet of LSD obtained from presumably different sellers on the street.
Subjective reports of the drug rated it at good quality with little or
no amphetamine impurities in it.

Dosage was probably less than 300 ug

(Cheek, Newel, and Joff, 1967).

During the approximately five hours of
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t e s t i n g , a l l Ss shifted in a negative d i r e c t i o n but with a small
(A = - 9 . 3 mv) magnitude.

The mean peak TCDC(FO) of the LSD users at

p r e - t e s t was -37 mv (range = -29 to -52) , and at t e s t time the mean was
- 4 6 . 3 mv (range = -34 to - 5 5 ) .

The mean s h i f t from p r e - t e s t to t e s t

was - 9 . 3 mv (range = -3 to - 2 0 ) .
Discussion

Hypnotic Groups. The results of the hypnotic studies suggested that the
TCDC technique cannot detect any hypnotic effect. Negative results were
found for the expected TCDC(FO) shift associated with hypnosis. The
expected negative shift associated with chemogenic and schizophrenic
hallucinations was not found nor was the expected positive shift associated with hypnoanalgesia.

Since the hallucinations were experienced,

it must be concluded that hypnotic hallucinations differ, at least in
their physiological mechanisms, from schizophrenic and chemogenic
hallucinations.
It is interesting to note that S9, a simulator, although beginning
the hypnotic session with a basal TCDC(FO) of -20 mv, shifted a full
20 mv in a negative direction, which is an abnormal TCDC(FO) in the
range of LSD users or hallucinating schizophrenics. Unfortunately,
there is no apparent explanation for this finding.

Perhaps the S^ had

used an unreported LSD-type drug in the past and was experiencing a
"flashback" effect.
Chemogenic Groups. As expected, there were no significant TCDC shifts
in the marijuana users.

This suggests that the mode of action of

27

marijuana i s different from t h a t of LSD.

The f a i l u r e to observe any

l a r g e s h i f t s due to the LSD i n t o x i c a t i o n i s probably a d i r e c t r e s u l t
of tolerance to LSD.
should have been used.

For t h i s study to be c l e a r e r , LSD-naive subjects
(See Study IV.)

STUDY IV

Purpose
Study IV was designed to examine the TCDC(FO) changes effected by
various psychedelic drugs in better controlled circumstances than in the
previous studies. Animals were selected as subjects not only to eliminate legal problems in administering LSD to humans, but also to eliminate scientific problems.

Cowen (1970b) has examined the effects of

LSD on the TCDC in rats and rabbits showing a positive correlation between peak negativity and reported strength of the hallucinogen
involved.

Method

Subjects:

The subjects were four juvenile rhesus monkeys from the

primate colony at the University of Waterloo.

Their weights ranged

from 3.6 to 5.9 kg.

Apparatus:

An eight-channel dynograph (Beckman, type R polygraph) with

low level dc input couplers was used for all recording.

As before,

Beckman biopotential skin electrodes were used with Beckman electrode
paste.

All testing of the animals was performed in an enclosure that

was copper-screened on all sides to eliminate artifacts due to stray
electromagnetic radiation.

Both S^ and E were grounded to the copper

screen by means of metal stretch bands about the wrist.
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The electrodes

were attached to the monkey and their output was split and fed to two
sets of two non-interacting channels on the dynograph set at 5 mv/cm
for baseline voltages and 0.5 mv/cm for transient shifts.
The three chemicals used in this study were:

1) tetrahydrocanna-

binol (DjTHC, National Institute of Mental Health Lot #61591) suspended
in fatty-acid free bovine albumin; 2) d-lysergic acid diethylamide-25
(LSD-25, Sandoz batch #69003); and 3) 2-brom-lysergic acid diethylamide
(B0L-148, Sandoz batch #433202) , a reportedly non-hallucinogenic analogue of LSD-25.
Procedure:

The E, anesthetized the animals with 60 mg/kg of Nembutal,

then shaved and washed their heads with alcohol before transporting them
to the copper-screened room.

The JE attached the electrodes, grounded

both himself and the S^ to the screen, and took basal TCDC(FO) recordings.
The animals were tested individually.

Of the four animals, only one

received LSD; the other three received control drugs.
Separate initial injections of NaCl and fatty-acid free bovine
albumin were given intraperitoneally to S4 to control for the TCDC(FO)
effects of both the injection itself and for the drug transport medium.
The E then injected IS1 with 3.5 cc of B0L-148 (5 mg/kg), S2 with .80 cc
of DjTHC (5 mg/kg), and £3 with .90 cc of LSD-25 (25 Ug/kg).

Continuous

recordings were, taken of the animals TCDC(FO) for a five-hour period.
Two days later, S3 received a second injection of LSD-25, and J32
received a second injection of D.THC under the same experimental conditions.

The injection of LSD-25 was .84 cc and the D,THC injection was
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a very large dose of 5.8 cc (36.25 mg/kg) to determine if indeed there
is a THC dosage effect.

The second LSD dose was injected to test for

a tolerance effect.

Results

No characteristic TCDC(FO) effects from either control drug
injection were detected.

The D,THC produced no discernible change in

the TCDC(FO), even in a large dose. BOL-148 produced a negative FO
shift of 11 mv, while the initial LSD-25 injection produced a negative
shift of 180 mv, a significant shift. The second LSD-25 injection produced a negative shift of 4.8 mv.

The TCDC(FO) effects of various com-

pounds in Nembutal-anesthetized monkeys are presented in Table 9.

INSERT TABLE 9 ABOUT HERE

Discussion
There were two provocative and expected findings.

The LSD-25

produced a negative shift in the TCDC of the anesthetized animal. The
DiTHC data, as expected, showed no change in the TCDC recordings. The
latter results indicated, as did the tolerance studies, that the mechanism of action of the two psychotropic drugs may be different. The
small negative shift caused by the injection of the BOL-148 may be due
to the fact that both LSD-25 and BOL-148 are serotonin antagonists (negative frontal shift is associated with uptake of serotonin in the brain.)

LSD-25 is a much more potent antagonist than BOL-148 and this may be
the mechanism of hallucination (Ray, 1972).
The lack of a large shift with the second injection of LSD-25 may
have been due to an overload effect much as that in Study III with the
LSD-active humans.

Two days after the initial LSD-25 injection and

anesthetized with Nembutal, which drives the TCDC(FO) in a positive
direction (near zero), the basal TCDC of the ^ was still negative.
This indicated that the bio-electrical changes induced by LSD-25 had
not yet subsided.
This study was somewhat confounded by the use of anesthetized as
opposed to fully-awake Ss. Unfortunately, surface electrodes cannot be
kept intact on a fully-awake rhesus monkey for any prolonged period of
time.

Because of the small number of subjects and a single LSD injec-

tion to a naive animal, this study must be considered suggestive rather
than substantive.

For a clearer picture of the LSD effects, a third

injection of LSD-25 should have been given to an S5 to see if the
dramatic negative shift was reproducable.
neither the S nor more LSD was available.

At this particular time,

SUMMARY OF FINDINGS

Study I showed a significant long-term change in the TCDC(FO)
activity after a single street dose of reported LSD.

The long term

change was not permanent, as noted by Study II. Study III showed a lack
of influence on the TCDC(FO) by marijuana, a seeming overload effect of
LSD, and it also gave no support to the hypothesis that hypnotic and
chemogenic hallucinations have a common mechanism of action.

Study IV,

using monkeys, supported the results of the human studies. LSD had a
strong effect upon the TCDC(FO) causing a large negative shift. There
seemed to be a tolerance effect caused by the LSD and, finally, LSD and
THC did not cause similar TCDC changes, which indicated that they have
different modes of action.

Discussion

The present studies replicated to some extent the pioneering work
of M. A. Cowen.

These studies indicated that Cowen's LSD studies in

rats and rabbits are repeatable in monkeys and humans and that the
changes are stable. However, the present studies did not support
Cowen's premise that the TCDC(FO) is related to hallucinations rather
than to biochemical changes in the brain.
LSD, unlike marijuana compounds, produced a relatively persistent
but not permanent change in the users' neurochemistry as reflected by
TCDC(FO) recordings.

Since there is no evidence to suggest that LSD is
32

33
retained in the organism more than twenty-four hours (Barber, 1970),
one possible explanation for this long-lasting change is that LSD
initiates a chain of biochemical reactions that continue long after the
LSD has been metabolized.

This long-term change may be associated with

changes in brain serotonin levels.
Hypnotic induction did not produce any characteristic TCDC(FO)
shifts.

This was in agreement with the Ravitz study but in direct oppoo

sition to that of Friedman, et al. At this time, these three studies
cannot be reconciled.

Hypnotically-induced hallucinations did not

produce the characteristic negative TCDC(FO) and (TT) shifts, and
hypnoanalgesia did not produce the expected positive shift reported by
Friedman, et al. The present results indicated either a differing
physiological mechanism for the hallucinations or that the TCDC effects
have really nothing to do with hallucinations but are influenced entirely
by biochemical changes that may or may not be related to hallucinations.
Certainly the Auerbach study, which found no evidence of hallucinations
induced by LSD in rhesus monkeys, would support the latter hypothesis.
These biochemical changes may in fact be a result of the attendant
anxiety associated with hallucinosis or may be related to the reality
testing process. Neither reality testing nor anxiety occurred in relation to the hypnotic hallucinations and perhaps that is the reason the
expected TCDC(FO) shifts did not occur.

There is even some question as

to whether hypnosis itself exists. Had the hypnoanalgesic suggestions
produced a positive TCDC(FO) shift, a further study involving the giving
of an LSD experience by hypnosis to a subject who had experienced LSD
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and who also had a normal basal TCDC recording (Fogel and Hoffer, 1962),
would have been carried out.
This long-term, non-permanent change in neurochemistry may account
for the occurrence of flashbacks (i.e., spontaneously recurring LSD experiences).

Pahnke and Richards (1966), and Smart and Bateman (1967),

reported that flashbacks typically occur when the individual is under
stress.

This suggestion was put forward because there has never been

any evidence to suggest that LSD is retained in the organism more than
twenty-four hours and also no evidence that LSD sets off a chain of biochemical reactions that continue after LSD is metabolized.

Results of

the present studies indicated that either LSD does indeed remain in the
body (Cowen, 1971, has suggested that the LSD may be bonded to DNA
molecules), or may set off a very long-lasting biochemical chain
reaction, i.e., drastic changes in serotonin levels.
The TCDC technique is a relatively simple electric technique for
studying biochemical changes in the brain.

Unfortunately, we do not yet

know enough about the neurochemistry of the brain for the technique to
be highly useful.

The technique is analogous to using a stethoscope to

study the heart. However, the stethoscope is useful only because we
know a great deal about the physiology and functioning of the heart.
Until we know more about the brain, the TCDC studies on behavioural
changes (hypnosis, recall, vivid imaginings, etc.) can only be descriptive.

At present they may add to our understanding of the brain but

cannot be used as a diagnostic tool.
The TCDC may best be used in neurochemical studies.

Sensitive
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enough to detect the presence of as little as five nanograms of LSD-25
in the brain of the rat, it can be used to monitor the existence and
the duration of neurochemical changes. At present, the TCDC can only
be used like a thermometer in that it can register an abnormality
without describing it. Although the research of Cowen points to the
glial cells as the generator of this electrical potential, it must be
remembered that this is still conjecture and perhaps the changes in
potential are a result of changes in other systems (i.e. , the sensory
apparatus).

LEGAL AND ETHICAL CONSIDERATIONS

Regardless of the scientific implications of these studies, it is
also necessary to examine some of the legal and ethical implications.
That the use of LSD is illegal does not mean that research on LSD users
is illegal.

Since no drugs were directly or indirectly provided for

the subjects, nor were the subjects explicitly or implicitly encouraged
.to use drugs (see Appendix A ) , no law was broken by the E.

The present

research is analogous to the many studies oh prostitution.

The re-

searchers in those studies neither encouraged nor condoned illegal
prostitution, but prostitution obviously had to take place in some sort
of connection with the research.

A difference with LSD research is that

it could be considered unethical not to study it if one of the outcomes
was evidence that the thousands of young LSD-users are irreversibly and
detectably altering their neurochemistry.
The question of legal privilege could be an important one.
Although the E_'s files could be subpoenaed by a court, all such files
are coded to avoid the use of the J3s' names. The only document that
was retained with names is the signed disclaimer to further protect the
University (see Appendix A ) .

Since all the subjects were required to

sign the disclaimer, it would be impossible to distinguish the drugusers from the non-users on the basis of this record.
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DIRECTIONS FOR FUTURE RESEARCH

To examine further the long-term TCDC(FO) changes induced by LSD,
one particular additional experiment may be proposed.

To eliminate the

problem of using anesthesia (which drives the TCDC(FO) positive), unanesthetized rabbits would be used.

Unlike monkeys, rabbits are easily

restrained and it is relatively easy to keep surface electrodes intact
on the head of a fully-awake rabbit. To insure an immediate effect of
the LSD on the animal, injections would be given through a surgicallyimplanted canula in the internal carotid artery of the animal. Continuous TCDC(FO) recordings could then be kept from the time of injection until the animal returned to its basal level. This data could be
compared with the metabolism rates of LSD-25 to determine whether or
not the TCDC changes persist after the LSD-25 has been metabolized.
Using this method and rabbits as subjects, the overload effects of LSD
could also be examined.
A number of researchers have been looking at the "endogenous
hallucinogen" theory as an explanation for the behavioural pattern in
some types of schizophrenia.

The principle treatment method based on

this theory is megavitamin therapy.
B3 and C.

The vitamins most often used are

There is considerable controversy about the effectiveness of

this particular treatment method.

Since the TCDC(FO) potential seems

to.be monitoring the biochemical changes associated with presumable
endogenous hallucinogens (i.e., bufotenin, DMPEA, and taraxein), perhaps
37
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it could be employed to detect changes, if any, in the neurochemistry of
the patient before and after megavitamin therapy.

If the patient before

treatment had a TCDC(FO) greater than -30 mv and after treatment had a
TCDC(FO) in the normal range and also exhibited more "normal" behavioural
patterns, then this would suggest some validity to the megavitamin treatment and, ultimately, to the endogenous hallucinogen theory.

If the

results of this proposed study were positive, they might indicate megavitamin therapy as a treatment for patients suffering from LSD-induced
psychosis.
The TCDC potential, like most other physiological events, is likely
conditionable.
his

It would be interesting to condition someone to control

TCDC and exhibit an abnormal negative TCDC and to record his sub-

jective impressions.

Those individuals who have learned to control EEG

occipital alpha waves report a feeling of euphoria. Perhaps those individuals who learn to control TCDC abnormal negative potentials would
report a feeling of being "spaced-out" and experiencing hallucinations.
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TABLE 1

A COMPARISON OF DIFFERING ALTERED STATES BY CRITERION
OF INSIGHT, VOLITION, AND CONSCIOUSNESS

Consciousness

Insight

Dream

0

0

0

Hypnogogic State

+

0

0

Hallucination

+

+

0

Daydream

+

+

+

Fantasy

+

+

+

0 - Largely Absent

+ - Largely Present

Volition
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FIGURE 1

ELECTRODE PLACEMENT FOR BOTH FRONTAL-OCCIPITAL
AND TRANSTEMPORAL RECORDINGS OF THE
TRANSCEPHALIC D.C. POTENTIAL
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TABLE 2
PEAK TCDC(FO) IN MV FOR LSD AND NON-DRUG SUBJECTS
BEFORE AND AFTER A SINGLE LSD-TYPE EXPERIENCE

s#

SEX

PEAK TCDC(FO)
T 1

T 2

ALLEGED
DRUG

PROBABLE
DRUG

AFTER

LSD

6

1

F

+12

+6

2
3

F
F

-1
+9

+2

4

M

+1

0

LSD

LSD

5

M

+5

-3

LSD

6

M

-8

+6

LSD

7

M

-3

+1

8

M

+9

+10

9

M

+5

10

M

Mescaline

# DAYS

PEAK TCDC(FO)
T 1
1 WK.

HALLUCINATE

T 2
T 3
T 4
2 WKS. 1 MO. 4 MOS.

-35

-30

-36

-28

+10

+11

+5

+10

5

-28

-30

No

LSD

7

-33

-28

No

LSD

6

-41

+5

Yes

+5

-2

-1

+6

-2

+2

-6

-8

Mean
C o n t r o l (N=4)

+3.3

+0

+4.3

+2.3

+5

+10

Mean LSD (N=4)

+2.5

+1

-34.3

-29.3

-36

-28

—

LSD

LSD

6

No
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FIGURE 2
PEAK TCDC(FO) FOR EACH DRUG-USER AND HIS MATCHED CONTROL
BEFORE AND AFTER A SINGLE LSD-TYPE EXPERIENCE
BEFORE
NON-USERS
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TABLE 3
TCDC(FO) RECORDING IN MV FOR FREQUENT USERS OF LSD
DURING A PERIOD OF HIGH USAGE AND AFTER ABSTINENCE

s#

TCDC(FO)
T 1 T 2

# OF
TRIPS

HALLUCINATE

1

-49

-33

9

Yes*

2

-16

-28

3

3

-22

-26

4

-38

5

LENGTH OF
ABSTINENCE
(BY WEEKS)

TCDC(FO)
T 3 T 4

9

+4

0

No

12

+7

+5

5

No

12

+12 +18

-31

13

No

20

+9

-27

-24

6

No

10

-10 -13

6

-62

-59

16

Yes**

16

-3

M

-35.7

-33.5

8.7

13.2

*

Visual

**

Auditory and Somatic

3.2

+11

+10

5.2

FIGURE 3
PEAK TCDC(FO) IN MV FOR LSD-ACTIVE SS DURING A PERIOD
OF HIGH USAGE AND AFTER A PERIOD OF ABSTINENCE
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FIGURE 4

STIMULUS FOR THE INDUCTION
OF POSITIVE HALLUCINATIONS

46

TABLE 4
REPORTED HYPNOTIC EXPERIENCES OF HYPNOTIZED
AND SIMULATING SUBJECTS

PHENOMENON

HYPNOTIZED

SUBJECT #

3 5 7

UNSTRUCTURED HALLUCINATION
(STAIRS)

-

-

Y

Y

I

DREAM INDUCTION

Y

N

Y

Y

Y

POSITIVE HALLUCINATION

N N Y

HYPNOTIZED

Y

Y

10

11

-

Y

Y

SIMULATED

1

-

-

Y

ANALGESIA

Y - Experienced the suggested phenomenon
N - Did not experience the phenomenon
I - Experienced imagery but did not experience
the suggested phenomenon

2

-

4

-

6

-

N

N

I

N

N

N

N

N

8

9

N

I

N

I

-

-

N N Y N N N

TABLE 5'
PEAK TCDC(FO) CHANGES IN MV OF HYPNOTIC SS AND OF SIMULATING SS ASSOCIATED
WITH HYPNOSIS PER SE, PRIOR TO HALLUCINATION INDUCTION

SIMULATOR

HYPNOTIC

S#

BASAL

PEAK

BASAL

CHANGE

3 '

4

-7

-4

-11

5

2

0

7

16

20

15

4

10

10

16

26

20

10

11

-28

-20

-20

8

+

0 - 2

HGSS

S#

8

1

10

8

2
4*
6

7

8
9

BASAL

PEAK

7

30

BASAL

CHANGE

30

23

5

5
4
4

-1

-3

-2

-2

0
-10

-7

.5

-7

-16

-13

-6

50

60

51

10

3

-20

-40

-32

-20

3

3

2

2

4

* S4 reported being hypnotized.

*,

HGSS
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TABLE 6
TCDC(FO) SHIFTS IN MV FOR EACH
HYPNOTIC PHENOMENON

HYPNOTIC

SIMULATOR

HALLUCINATIONS
S#

HALLUCINATIONS

UNSTRUCTURED DREAM POSITIVE HGSS S#

UNSTRUCTURED DREAM POSITIVE HGSS

8

1

-

0

10

2

-

-2

0

10

4

-

0 - 2

4

+1

+2

+1

8

6

-

+ 1 - 2

4

-1

0

7

8

0

0

3

9

0

-1

. 3

3

-

0

5

-

-1

7

0

10
11

+

1

-

1

0

5

0 - 1 . 5
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TABLE 7
PRE-DRUG AND DRUG-ACTIVE TCDC(FO) PEAK RECORDINGS
IN MV FOR MARIJUANA USERS

s#

PRE-TEST

1

-6

+4

+10

10

2

+5

+10

+5

5

1

3

-15

-10

-5

15

1

4

-2

-9

-7

5

3

5

-10

+1

+11

10

h

X

-5.6

-1.4

DRUG-ACTIVE

SHIFT

2.8

ELAPSED
MENS.
(APPROX.)

DOSAGE

% joint

1.2
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TABLE 8
PRE-DRUG AND DRUG-ACTIVE TCDC(FO) PEAK RECORDINGS
IN MV FOR STREET-LSD USERS

S#

PRE-TEST

DRUG-ACTIVE

SHIFT

ELAPSED
MINS.
(APPROX.)

1

-30

-50

-20*

10

2

-52

-55

-3

25

3

-29

-34

-5

15

X

-37

-46.3

-9.3

16.6

TABLE 9
A COMPARISON OF TCDC(FO) SHIFTS OF VARIOUS COMPOUNDS INJECTED
INTRAPERITONEALLY IN NEMBUTAL-ANESTHETIZED MONKEYS

SUBJECT
S#

WEIGHT
IN KG.

NEMBUTAL
60 MG/KG
CC.

1

5.9

3.5

2

3.8

2.5

3

3.6

2.3

4

4.35

2.8

2*

3.8

2.5

3*

3.6

2.3

*
**

TCDC(FO)
SHIFT

INJECTION
LSD
25 UG/KG
CC

NaCl
9 MG/
CC

THC
5 MG/KG
CC.

BOL-148
5 MG/KG
CC

BOVINE ALB. MAGNITUDE
25 GR/5 CC +
0
CC
11 MV

3.5
1

0

.80

.90

180 MV
4.00

3.8**
.84

a second i n j e c t i o n two days a f t e r the i n i t i a l i n j e c t i o n
a d e l i b e r a t e overdose (23.75 mg/kg) two days a f t e r the i n i t i a l i n j e r t i o n

0

+

1 MV
4.8 MV
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APPENDIX A

THE ADVERTISEMENT USED TO RECRUIT VOLUNTEER SUBJECTS

ELECTRIC COOL-AIDE ACID TEST

This study is concerned with whether or not the electrical
activity of the brain changes due to drug use.
If you volunteer, you will have two recording electrodes placed
on the scalp.

(These are not to be confused with shock electrodes;

absolutely no discomfort is involved.) You will be asked to sit quietly
for about ten minutes, during which you will be asked to concentrate on
a simple mental task, and then to just relax for about five more minutes.
You will then be given a detailed questionnaire on what drugs you
have taken.

I would like you to come back for repeat measurements once

a month for three months.

If you have used new drugs, this will help

us determine how they effect brain changes.

If you have not used any

new drugs, you will help us in determining the stability of our measuring techniques.

Consequently, the value of your participation does not

depend on your taking drugs during the experimental period.
Neither the researcher nor the universities with which he is affiliated in any way wish to encourage or condone the use of any non-medical
drug.

No drugs are supplied to subjects in conjunction with this project.

No payment or reimbursement of any kind can be offered for your participation.

However, interested parties may secure copies of research

reports resulting from this work.
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APPENDIX B

THE DRUG INVENTORY QUESTIONNAIRE USED TO
DETERMINE THE SUITABILITY OF THE SUBJECT

The following information will be coded and held in strict confidence.
Name:
Age:

Sex:

Academic Year:

1. Which of the following drugs have you ever used?

How long ago?

(Please indicate in each case, i.e. , a week, a month, a year.)
. ) coffee
) tea
) tobacco:

cigarettes ( ) , pipe ( ) , cigars ( )

) aspirin
) cold tablets, e.g., codeine ( ) , antihistamines ( ) , vitamins ( )
) steroid hormones, e.g., birth control pills
) stimulants, e.g., amphetamines - oral ( ) , intraveneously ( )
) tranquillizers

( ) marijuana

) sedatives

( ) hashish

) mescaline

( )

) LSD

( ) MDA

) STP

( ) belladonna

psilocybin

) others
2.

Which of the following drugs might you use within the next few weeks?

(

) coffee

( )

tea
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tobacco:

cigarettes ( ) , pipe ( ) , cigars ( )

aspirin
cold tablets, e.g., codeine ( ) , antihistamines ( ) , vitamins ( )
steroid hormones, e.g., birth control pills
stimulants, e.g., amphetamines - oral ( ) , intraveneously ( )
tranquillizers

( )

marijuana

sedatives

( ) hashish

mescaline

( )

LSD

( ) MDA

STP

( )

psilocybin

belladonna

others
3. Which of the following drugs do you ordinarily use, and how often?
coffee
tobacco:

( )

tea

cigarettes ( ) , pipe ( ) , cigars ( )

aspirin
cold tablets, e.g., codeine ( ) , antihistamines ( ) , vitamins ( )
steroid hormones, e.g., birth control pills
stimulants, e.g., amphetamines - oral ( ) , intraveneously ( )
tranquillizers

marxjuana

sedatives

hashish

mescaline

psilocybin

LSD

MDA

STP

belladonna

others
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APPENDIX C

LSD EFFECTS ON THE TCDC(FO) POTENTIAL: A PILOT STUDY

This pilot study was designed to determine whether or not "streetLSD" caused a negative shift in the transcephalic direct current potential (TCDC) in the user. No attempt was made to control for time of
testing, sex of the subject, temperature and humidity of the setting,
location of testing, or previous drug usage. Many of the subjects were
tested at "rock festivals" and in student lounges. However, some of the
j3s, including those reported in Study II, were tested under standard
conditions and using standard procedures.

Some of the subjects (both

users and non-users) in this pilot were personal friends of the experimenter.
The subjects were forty-three LSD-users and thirty-seven nonusers.

Presumably some of the Ss were drug-active at the time of test-

ing. Many of the ^s in both groups had used marijuana.
The S_ was asked if he would like to participate in the "Electric
Cool-Aide Acid Test" and was told that it was a test to determine
whether LSD caused changes in the brain.
discomfort would take place.

The S_ was assured that no

Electrodes (Beckman, biopotential) were

placed on the scalp over the frontal and occipital (FO) areas (see
Figure 1).

The wires of the electrodes were fed into a voltometer

(Digitest, Model 19) and the S_was asked to relax and close his eyes.
The TCDC(FO) was monitored for a five-minute period and the frontal
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s h i f t was noted and r e c o r d e d .
There was no o v e r l a p between t h e TCDC(FO) of LSD-users and nonusers.

No n o n - u s e r had a TCDC(FO) of l e s s than -16 mv (x = + 4 , range

= - 1 5 t o + 8 0 ) , and no LSD-user had a TCDC(FO) of g r e a t e r than -20 mv
(x = - 4 1 , range = - 7 1 t o - 2 0 ) .
The d a t a i n d i c a t e d t h a t LSD caused a f r o n t a l n e g a t i v e s h i f t
the TCDC(FO) n o t u n l i k e t h a t seen i n h a l l u c i n a t i n g

in

schizophrenics.

Because of t h e l a x c o n t r o l s i n t h i s p i l o t s t u d y , i t was i m p o s s i b l e t o
make any s t r o n g c o n c l u s i o n s .
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